EIDX Crosses Above Average Analyst Target
July 10, 2019 at 08:05 AM EDT
In recent trading, shares of Eidos Therapeutics Inc (EIDX) have crossed above the average analyst 12-month target price of $38.28, changing hands for $39.17/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..